Hugues Duffau

Jul 9, 2024 | bmccancer.biomedcentral.com | Xian Jin Xie |Chen Luo |Shuai Wu |Wanyu Qiao |Wei Deng |Lei Jin | +5 more

A cohort of 2879 infiltrating glioma cases who underwent tumor resection was obtained from the Department of Neurologic Surgery, Huashan Hospital, Fudan University, between 2013.06 and 2018.12. Eligible subjects are required to have undergone molecular marker tests and have complete information on the molecular markers, including IDH, 1p/19q, TERT, and MGMT. Individuals without information on any of the molecular markers were considered ineligible and excluded.

Feb 1, 2024 | thejns.org | Hugues Duffau |Mitchel Berger |Priscilla K Brastianos |Nader Sanai

Correspondence Hugues Duffau: [email protected]. INCLUDE WHEN CITING DOI: 10.3171/2023.11.FOCUS23731.

Aug 11, 2023 | thejns.org | Hugues Duffau

Share Link Copy this link, or click below to email it to a friend Email this content or copy the link directly: The link was not copied. Your current browser may not support copying via this button.